NASDAQ: $INSM Insmed Incorporated has officially announced its participation in a series of upcoming investor conferences throughout May 2026. This move signals a proactive effort by the biopharmaceutical company to maintain transparency and provide clarity regarding its ongoing clinical pipeline and commercial strategies. Why These Appearances Matter Investor conferences serve as a critical bridge between…